[Clinical characteristics of hepatocellular carcinoma in patients with antibody to hepatitis C virus].
Nagoshi
Sumiko
S
Department of Gastroenterology and Hepatology, Saitama Medical School.
Fujiwara
Kenji
K
D000367:Age Factors; D015415:Biomarkers / Q000097:blood; D006528:Carcinoma, Hepatocellular / Q000175:diagnosis / Q000453:epidemiology / Q000628:therapy / Q000821:virology*; D017115:Catheter Ablation; D016461:Chemoembolization, Therapeutic; D003952:Diagnostic Imaging; D000431:Ethanol / Q000008:administration & dosage; D006498:Hepatectomy; D018937:Hepatitis C Antibodies / Q000097:blood*; D006801:Humans; D015552:Injections, Intralesional; D007564:Japan / Q000453:epidemiology; D008113:Liver Neoplasms / Q000175:diagnosis / Q000453:epidemiology / Q000628:therapy / Q000821:virology*; D016031:Liver Transplantation; D009367:Neoplasm Staging; D011498:Protein Precursors / Q000097:blood; D011516:Prothrombin; D016036:Seroepidemiologic Studies; D012737:Sex Factors; D000509:alpha-Fetoproteins / Q000032:analysis
D015415:Biomarkers; D018937:Hepatitis C Antibodies; D011498:Protein Precursors; D000509:alpha-Fetoproteins; D000431:Ethanol; C008208:acarboxyprothrombin; D011516:Prothrombin